Conmed: Q4 Earnings Insights

Shares of Conmed CNMD were flat in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share were down 6.67% over the past year to $0.84, which beat the estimate of $0.76.

Revenue of $252,828,000 declined by 4.54% from the same period last year, which missed the estimate of $262,940,000.

Looking Ahead

The upcoming fiscal year's EPS expected to be between $2.85 and $3.05.

The upcoming fiscal year's revenue expected to be between $975,000,000 and $1,020,000,000.

Conference Call Details

Date: Jan 27, 2021

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/pxraknf4

Price Action

Company's 52-week high was at $121.56

Company's 52-week low was at $37.66

Price action over last quarter: Up 38.32%

Company Overview

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!